Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| GeneDx Holdings Corp.CL A(WGS) | 1,105,768 | 1,045,768 | -60,000 | $28.90M | $44.38M | 35.47% | +$15.48M |
| Biohaven Ltd.(BHVN) | 700,450 | 705,250 | +4,800 | $24.31M | $35.24M | 28.17% | +$10.93M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 225,000 | 749,487 | +524,487 | $2.32M | $13.55M | 10.83% | +$11.23M |
| Ardelyx Inc | 1,488,131 | 1,369,200 | -118,931 | $11.03M | $9.43M | 7.54% | -$1.59M |
| QuidelOrtho Corporation(QDEL) | 118,291 | 118,291 | 0 | $3.93M | $5.39M | 4.31% | +$1.46M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 535,558 | 535,558 | 0 | $3.31M | $4.07M | 3.25% | +$760.5K |
| Myriad Genetics, Inc.(MYGN) | 60,000 | 134,500 | +74,500 | $1.47M | $3.68M | 2.94% | +$2.22M |
| Forian Inc COM | 1,356,107 | 1,356,107 | 0 | $3.59M | $2.93M | 2.34% | -$664.5K |
| CAVA Group, Inc.(CAVA) | 18,600 | 18,600 | 0 | $1.73M | $2.30M | 1.84% | +$578.5K |
| Pacific Biosciences of California, Inc.(PACB) | 423,138 | 727,877 | +304,739 | $579.7K | $1.24M | 0.99% | +$657.7K |
| Springworks Therapeutics Inc | 233,200 | 34,200 | -199,000 | $8.78M | $1.10M | 0.88% | -$7.69M |
| Palantir Technologies Inc.CL A(PLTR) | 0 | 27,500 | +27,500 | $0 | $1.02M | 0.82% | +$1.02M |
| Biogen Inc.(BIIB) | 2,412 | 2,412 | 0 | $559.1K | $467.5K | 0.37% | -$91.6K |
| EyePoint, Inc.(EYPT) | 231,857 | 32,500 | -199,357 | $2.02M | $259.7K | 0.21% | -$1.76M |
| Biodesix, Inc.(BDSX) | 28,916 | 28,916 | 0 | $44.2K | $51.5K | 0.04% | +$7.2K |
| Agenus Inc.(AGEN) | 17,500 | 0 | -17,500 | $293.1K | $0 | — | -$293.1K |
| Walgreens Boots Alliance Inc | 27,500 | 0 | -27,500 | $332.6K | $0 | — | -$332.6K |